Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
Über diesen Artikel
Lineare Formel:
MnCl2
CAS-Nummer:
Molekulargewicht:
125.84
UNSPSC Code:
12352302
PubChem Substance ID:
MDL number:
eCl@ss:
38190105
Assay:
≥99%
Grade:
AR
Form:
crystalline powder
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltengrade
AR
product line
Vetec™
assay
≥99%
form
crystalline powder
pH
5.0-6.0 (5%)
mp
652 °C (lit.)
density
2.98 g/mL at 25 °C (lit.)
anion traces
sulfate (SO42-): ≤0.005%
cation traces
Ba: ≤0.01%, Ca: ≤0.03%, Cu: ≤0.0005%, Fe: ≤0.0005%, K: ≤0.01%, Mg: ≤0.005%, Na: ≤0.05%, Ni: ≤0.002%, Zn: ≤0.005%, heavy metals (as Pb): ≤0.0005%
SMILES string
Cl[Mn]Cl
InChI
1S/2ClH.Mn/h2*1H;/q;;+2/p-2
InChI key
GLFNIEUTAYBVOC-UHFFFAOYSA-L
Legal Information
Vetec is a trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under Mangan(II)-chlorid
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral - Eye Dam. 1 - STOT RE 2
target_organs
Brain
Lagerklasse
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Verwandter Inhalt
Geoffrey J Topping et al.
Medical physics, 40(4), 042502-042502 (2013-04-06)
Manganese(II) is employed as a contrast agent with magnetic resonance imaging (MRI) for study of neuronal activation in rats and mice. However, at the concentrations required for MRI, Mn may induce pharmacological or toxic effects. Positron emission tomography (PET) imaging
Jerome A Roth et al.
Neurotoxicology, 35, 121-128 (2013-01-15)
Chronic exposure to Mn results in the development of a neurological disorder known as manganism characterized by neurological deficits resembling that seen in Parkinsonism. Although dopaminergic neurons within the nigrostriatal pathway appear intact, Mn-induced irregularities in DA transmission have been
Anne Bertrand et al.
NeuroImage, 64, 693-702 (2012-09-11)
The impairment of axonal transport by overexpression or hyperphosphorylation of tau is well documented for in vitro conditions; however, only a few studies on this phenomenon have been conducted in vivo, using invasive procedures, and with contradictory results. Here we


